methods for identifying an asthma patient, method for monitoring an asthma patient, use of a total periostin detection kit, total periostin measurement kit, use of an anti-il-13 antibody, use of a therapeutically amount lebrikizumab therapy, use of a th2 pathway inhibitor, adverse event evaluation method, anti-periostin antibody, and total periostin test

摘要

“Methods of identifying an asthma patient, method of monitoring an asthma patient, use of a total periostin detection kit, total periostin measurement kit, use of an anti-il-13 antibody, use of an amount lebrikizumab therapy, use of a th2 pathway inhibitor, adverse event assessment method, anti-periostin antibody, and total periostine test ”are provided Diagnostic methods and treatment of disorders related to th2 inhibition, including but not limited to , asthma. Patient selection or identification methods are also provided for treatment with certain therapeutic agents that are th2 pathway inhibitors.